In Vitro Differentiation Potential of Human Placenta Derived Cells into Skin Cells

Figure 3

Immunostaining for UC-MSCs; (a) CD 45 negative. (b)–(d) CD49, CD73, and CD90 positive. (e) shows percentage of positive cells. RT-PCR for UC-MSCs; (f) CD29, CD44, CD73, and CD 90 positive.

(a)

(b)

(c)

(d)

(e)

(f)